Study of a new drug for high cholesterol
Treatments studied
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- Your LDL cholesterol (the 'bad' cholesterol) must be above a certain level, depending on your heart disease risk.
- Your fasting triglycerides (a type of fat in your blood) must be below 4.5 mmol/L.
- If you take cholesterol-lowering medication, the dose must stay the same for at least 4 weeks before starting.
- You should be in generally stable health, without severe heart problems or recent cardiovascular events.
- Women who are pregnant or breastfeeding cannot participate, and all participants must use effective contraception during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational medicine (QLC7401) that aims to lower LDL ('bad') cholesterol when added to your current cholesterol-lowering therapy. If you are already on a statin but your cholesterol is still not low enough, this trial might help you reach your goals.
This trial tests a new medicine called QLC7401 to lower cholesterol in adults with high cholesterol who are not currently on cholesterol-lowering treatment. It may help reduce the risk of heart problems.
This trial tests a new medicine that aims to lower LDL (bad) cholesterol in healthy adults. It will help doctors understand how the medicine works in the body and how safe it is.
This study tests an investigational medicine called QLC7401 for people with a genetic condition called heterozygous familial hypercholesterolemia, which causes very high cholesterol. It aims to see if the new medicine can further lower bad cholesterol when added to your usual cholesterol treatments.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
This trial tests an investigational medicine (SHR-1918) added to your current statin therapy to see if it helps lower your LDL ('bad') cholesterol and triglycerides more than a placebo. It may be an option if you're on a statin but still have high cholesterol.
Hear when a new Primary Hypercholesterolemia or Mixed Hyperlipidemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.